Jan 13, 2020 / 09:30PM GMT
Cory William Kasimov - JP Morgan Chase & Co, Research Division - Senior Biotechnology Analyst
All right. Good afternoon, everyone. My name is Cory Kasimov. I'm the senior biotech analyst at JPMorgan. It's my pleasure to introduce the next company. I'm glad Jamie stopped talking to give him his full allotment, but we have Sage Therapeutics and the company's CEO, Jeff Jonas, with us. Please note that following Jeff's presentation, there will be a breakout across the hall in the Georgian room.
With that, I turn it over to Jeff.
Jeffrey M. Jonas - Sage Therapeutics, Inc. - CEO, President & Director
Good afternoon, everyone. Thanks for coming. Just before this started, I was given the opportunity to cut off Jamie. I wisely declined. The -- so this is our safe harbor. And again, we're going to be making some forward-looking statements today. Refer to our filings for further details.
I'm going to begin today with a little bit of an overview of what's made Sage -- what's driven the folks at Sage. What we think -- what our vision really is and
SAGE Therapeutics Inc at JPMorgan Healthcare Conference Transcript
Jan 14, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers